Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Whitcup

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|February 13, 2016
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDYRaj K Maturi, Ayala Pollack, Harvey S Uy, et al.
Ophthalmology|June 8, 2014
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaDavid S Boyer, Young Hee Yoon, Rubens Belfort, et al.
Retina (Philadelphia, Pa.)|February 23, 2017
ReplyRaj K Maturi, Ayala Pollack, Harvey S Uy, et al.
Investigative Ophthalmology & Visual Science|June 14, 2013
Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitisSusan Lightman, Rubens Belfort, Rupali K Naik, et al.
Investigative Ophthalmology & Visual Science|July 31, 2002
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eyeMichael E Stern, Jianping Gao, Tammy A Schwalb, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 20, 2015
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled TrialBaruch D Kuppermann, Michaella Goldstein, Raj K Maturi, et al.
American Journal of Ophthalmology|March 27, 2017
ReplyVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 29, 2016
Bimatoprost 0.03% for the Treatment of Eyebrow HypotrichosisJean Carruthers, Kenneth Beer, Alastair Carruthers, et al.
Eye (London, England)|July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I dataSrinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
Retina (Philadelphia, Pa.)|February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study DataPravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|February 13, 2016
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDYRaj K Maturi, Ayala Pollack, Harvey S Uy, et al.
Ophthalmology|June 8, 2014
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaDavid S Boyer, Young Hee Yoon, Rubens Belfort, et al.
Retina (Philadelphia, Pa.)|February 23, 2017
ReplyRaj K Maturi, Ayala Pollack, Harvey S Uy, et al.
Investigative Ophthalmology & Visual Science|June 14, 2013
Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitisSusan Lightman, Rubens Belfort, Rupali K Naik, et al.
Investigative Ophthalmology & Visual Science|July 31, 2002
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eyeMichael E Stern, Jianping Gao, Tammy A Schwalb, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 20, 2015
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled TrialBaruch D Kuppermann, Michaella Goldstein, Raj K Maturi, et al.
American Journal of Ophthalmology|March 27, 2017
ReplyVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 29, 2016
Bimatoprost 0.03% for the Treatment of Eyebrow HypotrichosisJean Carruthers, Kenneth Beer, Alastair Carruthers, et al.
Eye (London, England)|July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I dataSrinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
Retina (Philadelphia, Pa.)|February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study DataPravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
Pageof 7